Chicago, USA – DPH Biologicals® has announced significant breakthroughs in the mode of action and performance of its flagship next-generation biofertilizer, TerraTrove® AmplAphex™. Backed by multi-year field trials and scientific research, the product has shown a transformative impact on both crop yields and soil health.

AmplAphex™, powered by the RegenAphex™ Technology Platform, builds upon the trusted legacy of SP-1 Classic® while introducing an advanced formulation developed through a newly implemented manufacturing process. This innovation delivers a lower use rate and higher performance, offering growers a more efficient and sustainable solution.

According to DPH Biologicals, the breakthrough findings in AmplAphex’s mode of action highlight how the product interacts with soil biology to improve nutrient cycling, root development, and plant vigor. The comprehensive field trial program, conducted over several years and various geographies, consistently demonstrated significant yield increases across multiple crops.

“AmplAphex™ is more than just an evolution of SP-1 Classic® — it’s a leap forward in regenerative input technology,” the company stated. “This product reflects our commitment to combining biological innovation with practical agronomic benefits, helping farmers meet the growing demand for productivity and sustainability.”

DPH Biologicals’ continued investment in research and technology platforms like RegenAphex™ reaffirms its position as a leader in the biologicals sector, delivering solutions that address the twin goals of improved crop performance and enhanced soil ecology.

As regenerative agriculture continues to gain traction, AmplAphex™ stands out as a cutting-edge tool that enables farmers to optimize inputs, reduce environmental impact, and achieve long-term productivity.